BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Yamamoto T, Hayashi S, Kadowaki M. Suppression of plasmacytoid dendritic cell migration to colonic isolated lymphoid follicles abrogates the development of colitis. Biomed Pharmacother 2021;141:111881. [PMID: 34246191 DOI: 10.1016/j.biopha.2021.111881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Liu F, Pan Y, Xiong Y, Zeng X, Zheng L, Zhao H, Li Y, Liu D. Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway. Int Immunopharmacol 2023;115:109612. [PMID: 36584572 DOI: 10.1016/j.intimp.2022.109612] [Reference Citation Analysis]
2 Sun D, Li C, Chen S, Zhang X, Koon HW. Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease. BioMed Research International 2022;2022:1-6. [DOI: 10.1155/2022/7025634] [Reference Citation Analysis]
3 Kanauchi Y, Yamamoto T, Yoshida M, Zhang Y, Lee J, Hayashi S, Kadowaki M. Cholinergic anti-inflammatory pathway ameliorates murine experimental Th2-type colitis by suppressing the migration of plasmacytoid dendritic cells. Sci Rep 2022;12:54. [PMID: 34997096 DOI: 10.1038/s41598-021-04154-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]